Literature DB >> 26129677

Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.

Pauline Belujon1, Nicole L Jakobowski1, Hannah K Dollish1, Anthony A Grace1.   

Abstract

Drug addiction is a chronic disorder characterized by a cycle composed of drug seeking, intoxication with drug taking and withdrawal associated with negative affect. Numerous studies have examined withdrawal/negative affect after chronic use; however, very few have examined the effect of acute administration on the negative affective state after acute drug withdrawal. One dose of amphetamine was injected into Sprague-Dawley rats. Despair behavior using the modified forced swim test (FST) and dopamine (DA) activity in the ventral tegmental area using in vivo electrophysiological recordings were studied 18, 48 and 72 h after injection of amphetamine. The effects of inactivation of the basolateral amygdala (BLA) and ketamine administration on VTA DA neuron activity and passivity in the modified FST were examined. Eighteen hours following amphetamine withdrawal, there was a substantial decrease in the number of active DA neurons, as well as an increase in time spent immobile in the modified FST, which returned to baseline after 72 h. Inactivation of the BLA after acute amphetamine prevented the decrease in DA neuron tonic activity. Injection of ketamine also prevented the decrease in DA population activity but had no effect on immobility measured in the modified FST. The data support a model in which the negative affective state following acute amphetamine withdrawal is associated with a decrease in DA neuron population activity, driven by hyperactivity of the BLA. Although ketamine reversed the hypodopaminergic state following withdrawal, the failure to reduce immobility in the modified FST indicates that different processes underlying negative emotional state may exist between depression and drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26129677      PMCID: PMC5130137          DOI: 10.1038/npp.2015.191

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  56 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

2.  Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.

Authors:  John F Cryan; Daniel Hoyer; Athina Markou
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

3.  Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

Review 4.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 5.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 6.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

7.  Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors.

Authors:  W X Shi; C L Pun; P L Smith; B S Bunney
Journal:  Synapse       Date:  2000-02       Impact factor: 2.562

8.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

Authors:  E Carboni; A Imperato; L Perezzani; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

9.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

10.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

View more
  26 in total

1.  Prior Exposure to Salient Win-Paired Cues in a Rat Gambling Task Increases Sensitivity to Cocaine Self-Administration and Suppresses Dopamine Efflux in Nucleus Accumbens: Support for the Reward Deficiency Hypothesis of Addiction.

Authors:  Jacqueline-Marie N Ferland; Tristan J Hynes; Celine D Hounjet; David Lindenbach; Cole Vonder Haar; Wendy K Adams; Anthony G Phillips; Catharine A Winstanley
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

Review 3.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

Review 4.  New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders.

Authors:  Elias Dakwar; Edward V Nunes
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

Review 5.  The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.

Authors:  Kathryn G Commons; Aram B Cholanians; Jessica A Babb; Daniel G Ehlinger
Journal:  ACS Chem Neurosci       Date:  2017-03-22       Impact factor: 4.418

6.  Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress.

Authors:  Jared L Moreines; Zoe L Owrutsky; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2016-11-04       Impact factor: 7.853

7.  Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.

Authors:  Kathryn M Gill; Sarah A Miller; Anthony A Grace
Journal:  Schizophr Res       Date:  2017-09-18       Impact factor: 4.939

8.  The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.

Authors:  Eric C Zimmerman; Anthony A Grace
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

Review 9.  Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate.

Authors:  A J Robison; Katharine N Thakkar; Vaibhav A Diwadkar
Journal:  Biol Psychiatry       Date:  2019-10-03       Impact factor: 13.382

Review 10.  Modelling depression in animals: at the interface of reward and stress pathways.

Authors:  D A Slattery; J F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2017-02-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.